The Global Organization for EPA and DHA has warned the supplement industry that "that there is an insufficient body of scientific literature to connect EPA/DHA to benefits of either positive general or viral immunity outcomes in a healthy population," and they should be wary of making "immunity" claims in labeling and advertising. "It is also worth mentioning that the US Food and Drug Administration and Federal Trade Commission are closely watching for misleading product claims around COVID-19 prevention or treatment and even a general 'immunity' claim on a product could be considered an implied claim about COVID-19 given the current environment," the group said.
Omega-3 supplement industry warned about "immunity" claims
Sign up for Inform SmartBrief
Global fats and oils news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.